Share
To invite people, share this page:
COPY
More from AI in Biopharma →
About
This interactive discussion featured Harry Glorikian, author of MoneyBall Medicine joined by Ülo Palm, Thomas Bock, and Lixia Wang discussing their current work and future outlook along with the important work that The APANDEMIC Initiative has set out to do.
Price
Free
Language
English
Who can attend
Everyone
Dial-in available? (listen only)
Not available.
Agenda
  • The definition of RWE
  • Examples of companies that are effectively working with biopharma to ensure that RWD is thoughtfully collected and analyzed to turn it into a powerful tool
  • The ability of RWE to predict future pandemics
  • Challenges to adoption
  • Privacy concerns
  • The potential over reliance on p-values
  • RCT’s (random clinical trials) limitations on drug efficacy in big populations
  • Working with regulators

Hosted By AI in Biopharma
  • AI in Biopharma webinar platform hosts Leveraging RWE and advanced analytics: The need for a modernized drug development model in a pandemic
    We connect the industry’s science minds, AI technology experts, technologists, and strategy leaders through in-person and virtual events and digital content. Our large community of industry leaders are passionate about the work they do and are dedicated to working at the intersection of science and technology. We collaborate with our industry experts to convene engaged discussions and facilitate the translation of AI/ML technologies into patient impact.
    Other Events Contact
Featured Presenters
Conversation
Powered by BigMarker